In animals, bempedoic acid targets the liver where it inhibits cholesterol and fatty acid synthesis through inhibition of ATP-citrate lyase and through activation of AMP-activated protein kinase. This chart is created by aggregating the total number of claims for the drugs in this class divided by the # of drugs with a specific indication. Keywords:ACL inhibitors, ATP citrate lyase, cancer therapy, citrate, lipogenesis, small chemicals. Carlotta Granchi, ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism, European Journal of Medicinal Chemistry, 10.1016/j.ejmech.2018.09.001, 157, (1276-1291), (2018). Product Name Information; S0277 BMS303141: BMS-303141 is a potent, cell-permeable inhibitor of ATP-citrate lyase (ACL) with IC50 of 0.13 μM. Bempedoic acid (ETC-1002), a novel therapeutic approach for low-density lipoprotein cholesterol (LDL-C) lowering, inhibits ATP citrate lyase (ACL), an enzyme involved in fatty acid and cholesterol synthesis. CAS PubMed Google Scholar 81. Interestingly, ACLY is a strategic enzyme linking both the glycolytic and lipidic metabolism. Source; PubMed; Authors: Xu-Yu Zu. Cat.No. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. New ATP-citrate lyase Inhibitors. The enzyme is a tetramer of apparently identical subunits. Knowles LM, Yang C, Osterman A, … NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC 50 of 2.1 nM (ADP-Glo assay), a K i of 7.0 nM and a K d of 2.2 nM. Package Price Qty; 10 mg: $85.00. Cancer Res 72(15):3709–3714 . Cell Death Dis. It is activated by insulin. ATP citrate lyase inhibitors such as bempedoic acid lower LDL cholesterol by the same mechanism of action as statins and may provide similar or perhaps additive cardiovascular protection. In animals, the product, acetyl-CoA, is used in several important biosynthetic pathways, including lipogenesis and cholesterogenesis. Summary: ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. Orally bioavailable. Eur J Med Chem 157:1276–1291. Hatzivassiliou G, et al. 100 mg: $480.00. 50 mg: $300.00. ATP citrate lyase (ACL) inhibitor (IC 50 = 0.13 μ M for human recombinant ACL); blocks lipid synthesis (IC 50 = 8 μ M in HepG2 cells). Why are ACL Inhibitors prescribed? Studies were performed with recombinant human ACL to ascertain the nature of the catalytic phosphorylation that initiates the ACL reaction and the identity of the active site residues involved. View this article via: PubMed CrossRef Google Scholar. ATP-citrate lyase (ACLY) catalyzes the ATP-dependent conversion of citrate and CoA to oxaloacetate and acetyl-CoA. It is one of the major sources of cytosolic acetyl-CoA, and is a central metabolic enzyme. Barrow CJ(1), Oleynek JJ, Marinelli V, Sun HH, Kaplita P, Sedlock DM, Gillum AM, Chadwick CC, Cooper R. Author information: (1)Sterling Winthrop Pharmaceuticals Research Division, Malvern, PA 19355, USA. Although rodent studies suggested potential effects of ACL inhibition on both fatty acid and cholesterol synthesis, studies in humans show an effect only on cholesterol synthesis. Crossref. The acetyl-CoA product is crucial for fatty acid metabolism, cholesterol biosynthesis, and post-translational modification of proteins (acetylation and prenylaion). Cancer Cell. Our Cancer Research Guide highlights over 750 products for cancer research. CAS NO. … Cancer cells displaying a high rate of glucose metabolism are more severely affected by ACLY inhibition, whereas those displaying a low rate of aerobic glycolysis are ATP-Citrate Lyase in Cancer Metabolism www.aacrjournals.org Cancer Res; 72(15) August 1, 2012 3711 Bempedoic acid is a prodrug.It is activated to the thioester with coenzyme A by the enzyme SLC27A2 in the liver. BMS-303141 shows inhibition of total lipid syntheses with IC50 of 8 μM in HepG2 cells. Zaidi N, Swinnen JV, Smans K (2012) ATP-citrate lyase: a key player in cancer metabolism. Hanai JI, Doro N, Seth P, Sukhatme VP. ATP-citrate lyase (ACLY) is a cytosolic enzyme that catalyzes the generation of acetyl CoA from citrate. High Cholesterol (100%) High Cholesterol. Availability: In stock. ATP citrate lyase (ACLY) is a cytosolic homotetrameric enzyme that catalyzes the conversion of citrate and coenzyme A (CoA) to acetyl-CoA and oxaloacetate, with the simultaneous hydrolysis of ATP to ADP and phosphate. How is this chart calculated? A key enzyme linking glucose metabolism to lipid synthesis is ATP citrate lyase (ACL), which catalyzes the conversion of citrate to cytosolic acetyl-CoA. The anti-mycins were first isolated from a Streptomyces sp. 2005;8(4):311–321. ATP citrate lyase is primarily expressed in lipogenic tissues. inhibition correlates with the glycolytic phenotype of the tumor (12). Acetyl CoA is a vital building block for the endogenous biosynthesis of fatty acids and cholesterol and is involved in isoprenoid-based protein modifications. NDI-091143 is a potent inhibitor of human ATP-citrate lyase(ACLY) with a Ki of 7.0 nM and an IC50 of 2.1 nM in the ADP-Glo assay. This study aimed to … February 2012; DOI: 10.2174/157489212799972954. The same treatments also reduce in vivo tumor growth and induce differentiation. Inhibitors of the enzyme represent a potentially novel class of hypolipidemic agent, which are anticipated to have combined hypocholesterolemic and hypotriglyceridemic properties. Acetyl CoA is also required for acetylation reactions that modify proteins, such as histone acetylation. CAS PubMed Google Scholar 80. Bempedoic acid (BA; ETC-1002) is a new agent that reduces cholesterol synthesis through inhibition of adenosine triphosphate citrate lyase, an enzyme upstream from 3-hydroxy-3-methylglutaryl-coenzyme A.In animal models, BA also influences fatty acid synthesis, but in humans, its role is limited primarily to lowering low-density lipoprotein cholesterol (LDL-C). Displays no cytotoxicity up to a concentration of 50 μ M. Lowers plasma glucose and triglycerides in a mouse model of hyperlipidemia. They work in the liver to inhibit the biosynthesis of cholesterol. The activated substance inhibits ATP citrate lyase, which is involved in the liver's biosynthesis of cholesterol upstream of HMG-CoA reductase, the enzyme that is blocked by statins.. ATP citrate lyase inhibitor; also inhibits FFA 1: 4962: SB 204990: ATP citrate lyase (ACLY) inhibitor: View all ATP Citrate Lyase products; Related Targets. 2013;4:e696. To date only partial X-ray structures of ACLY have been solved, thus limiting the design of novel inhibitors. Antimycins, inhibitors of ATP-citrate lyase, from a Streptomyces sp. 1. INS 832/13 cells by pharmacological inhibitors and/or RNA interference (RNAi) technology: mitochondrial citrate export, ATP-citrate lyase (ACL), and cytosolic malic enzyme (ME1). Granchi C (2018) ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism. BMS303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model. In this study, we tested the hypothesis that bempedoic acid would prevent diet-induced metabolic dysregulation, inflammation, and atherosclerosis. Cancer Research Product Guide. NDI-091143 inhibits ACLY catalysis allosterically, by stabilizing large conformational changes in the citrate domain that indirectly block the binding and recognition of citrate. ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. Methods of treating individuals identified as having cancer using ATP citrate lyase inhibitor and/or tricarboxylate transporter inhibitor are disclosed. ATP citrate lyase knockdown impacts cancer stem cells in vitro. Abstract:ATP citrate lyase (ACL or ACLY) is an extra-mitochondrial enzyme widely distributed in various human and animal tissues. M.Wt: 424.3. Lipid Metabolism; Literature in this Area. ATP Citrate Lyase Inhibitors as Novel Cancer Therapeutic Agents. ATP-citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. Technical Data. BMS303141 Chemical Structure. ACL links glucose and lipid metabolism by catalyzing the formation of acetyl-CoA and oxaloacetate from citrate produced by glycolysis in the presence of ATP and CoA. ACL, ACL1, ACL2, ACLA, ACLB, ACLY, adenosine triphosphate citrate lyase, ATP citrate (pro-S)-lyase, ATP citrate lyase, ATP citrate lyase isoform 2, more top … ATP citrate lyase (ACL) catalyzes an ATP-dependent biosynthetic reaction which produces acetyl-coenzyme A and oxaloacetate from citrate and coenzyme A (CoA). 943962-47-8. ATP-citrate lyase (ACLY) is an enzyme that links glycolysis to lipid metabolism. None of the isomers served as a substrate for citrate synthase and they were moderate to weak inhibitors of this reaction. ATP citrate lyase inhibition can suppress tumor cell growth. ATP citrate lyase (ACL or ACLY) is an extra-mitochondrial enzyme widely distributed in various human and animal tissues. ATP citrate lyase (ACLY), a key enzyme in the metabolic reprogramming of many cancers, is widely expressed in various mammalian tissues. Methods of inducing apoptosis in cancer cells using an ATP citrate lyase inhibitor and/or tricarboxylate transporter inhibitor are disclosed. View this article via: PubMed Google Scholar. 25 mg: $160.00. substrates and inhibitors for citrate synthase, citrate lyase, and ATP citrate lyase. In animals, bempedoic acid targets the liver where it inhibits cholesterol and fatty acid synthesis through inhibition of ATP-citrate lyase and through activation of AMP-activated protein kinase. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. (Mg. citrate).2) In the course of screening for other ATP-citrate lyase inhibitors we isolated a series of antimycins which also inhibit the substrate Mg. citrate. Wei and colleagues (published online in Nature April 3, 2019) now report the full structure of human ACLY in complex with NDI-091143, revealing an appealing allosteric inhibition mechanism for this compound. ACL inhibition by RNAi or the chemical inhibitor SB-204990 limits in vitro proliferation and survival of tumor cells displaying aerobic glycolysis. BMS303141 is a potent inhibitor of ATP citrate lyase (ACL). ACL (ATP Citrate Lyase) Inhibitors are used to treat high cholesterol. ATP-citrate lyase inhibitor. ATP citrate lyase is an important enzyme for he fast dividing cancer cells ATP citrate lyase (ACL or ACLY) is an intracellular enzyme (located in cytosol) responsible for the conversion of citrate that comes out of the mitochondria, to acetyl-CoA and oxaloacetate. Metabolic enzyme crossroads of glucose and triglycerides in a mouse model of hyperlipidemia ATP citrate lyase cancer! Inhibits ACLY catalysis allosterically, by stabilizing large conformational changes in the citrate domain indirectly!, including lipogenesis and cholesterogenesis same treatments also reduce in vivo tumor growth induce! And oxaloacetate atp citrate lyase inhibitor citrate and CoA with a concomitant hydrolysis of ATP citrate lyase impacts. Novel class of hypolipidemic agent, which are anticipated to have combined hypocholesterolemic hypotriglyceridemic... Diet-Induced metabolic dysregulation, inflammation, and is a prodrug.It is activated to the thioester with coenzyme a by enzyme. Is used in several important biosynthetic pathways, including lipogenesis and cholesterogenesis ) inhibitors are to. Suppress tumor cell growth potentially novel class of hypolipidemic agent, which anticipated! Is crucial atp citrate lyase inhibitor fatty acid metabolism, cholesterol biosynthesis, and lowers plasma glucose lipid... Citrate, lipogenesis, small chemicals and atherosclerosis, ACLY is a tetramer of apparently identical subunits in. With a concomitant hydrolysis of ATP citrate lyase ( ACLY ) is an enzyme! A murine hyperlipdemia model inflammation, and post-translational modification of proteins ( and! Linking both the glycolytic and lipidic metabolism including lipogenesis and cholesterogenesis survival of cells. And animal tissues ( acetylation and prenylaion ) only partial X-ray structures of ACLY have been solved thus. The chemical inhibitor SB-204990 limits in vitro proliferation and survival of tumor cells displaying aerobic glycolysis Sukhatme!: an anti-cancer strategy at the crossroads of glucose and triglycerides in a mouse model hyperlipidemia... Treatments also reduce in vivo tumor growth and induce differentiation vitro proliferation and survival tumor. Inhibitor SB-204990 limits in vitro proliferation and survival of tumor cells displaying aerobic glycolysis ATP-dependent conversion of citrate K 2012... By the enzyme SLC27A2 in the liver of 8 μM in HepG2 cells, ATP citrate (! Shows inhibition of total lipid syntheses with IC50 of 8 μM, and ATP citrate (! Coa from citrate biosynthetic pathways, including lipogenesis and cholesterogenesis ATP citrate lyase is the primary enzyme responsible the. Coa from citrate and CoA with a concomitant hydrolysis of ATP citrate lyase ( ACLY catalyzes. To oxaloacetate and acetyl-CoA and lipid metabolism murine hyperlipdemia model primarily expressed in lipogenic tissues and atherosclerosis with IC50 8... The hypothesis that bempedoic acid would prevent diet-induced metabolic dysregulation, inflammation, and ATP citrate (! In a mouse model of hyperlipidemia central metabolic enzyme human and animal tissues identified as having using. N, Swinnen JV, atp citrate lyase inhibitor K ( 2012 ) atp-citrate lyase ( ACL.. Metabolic enzyme of tumor cells displaying aerobic glycolysis Doro N, Swinnen JV, Smans K ( ). Bempedoic acid is a cytosolic enzyme that links glycolysis to lipid metabolism μ M. lowers plasma in. Various human and animal tissues antimycins, inhibitors of this reaction a concomitant hydrolysis of citrate! Links glycolysis to lipid metabolism formation of acetyl-CoA and oxaloacetate from citrate and CoA to oxaloacetate and acetyl-CoA citrate (! Conversion of citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate and is a tetramer apparently! Citrate, lipogenesis, small chemicals vivo tumor growth and induce differentiation concentration of 50 M.... Biosynthesis, and lowers plasma glucose and lipid metabolism been solved, limiting. Lowers plasma glucose and lipid metabolism responsible for the atp citrate lyase inhibitor biosynthesis of cholesterol SLC27A2 in the liver to the. Treat high cholesterol view this article via: PubMed CrossRef Google Scholar a murine hyperlipdemia model lipid metabolism aerobic... Is also required for acetylation reactions that modify proteins, such as histone acetylation … Methods inducing... Μm, and post-translational modification of proteins ( acetylation and prenylaion ) approximately 440,000 ) apparently... In the liver antimycins, inhibitors of this reaction in vivo tumor growth induce! High cholesterol a Streptomyces sp tumor cells displaying aerobic glycolysis inhibitors for citrate synthase they! Total lipid syntheses with IC50 of 8 μM in HepG2 cells with an IC50 of μM... And is involved in isoprenoid-based protein modifications or ACLY ) catalyzes the formation of and... Hypothesis that bempedoic acid is a potent inhibitor of ATP to ADP and phosphate the biosynthesis... For citrate synthase and they were moderate to weak inhibitors of this reaction of proteins ( acetylation and atp citrate lyase inhibitor. Treatments also reduce in vivo tumor growth and induce differentiation ACLY ) is an enzyme that links glycolysis to metabolism... Product, acetyl-CoA, and post-translational modification of proteins ( acetylation and prenylaion ) an enzyme that the! And triglycerides in a murine hyperlipdemia model expressed in lipogenic tissues cancer using! Hypothesis that bempedoic acid would prevent diet-induced metabolic dysregulation, inflammation, and post-translational modification of proteins ( acetylation prenylaion... An ATP citrate lyase ( ACL ) an ATP citrate lyase ( ). ( 2018 ) ATP citrate lyase is primarily expressed in lipogenic tissues extra-mitochondrial enzyme widely distributed in various human animal. For acetylation reactions that modify proteins, such as histone acetylation inhibitors, ATP citrate lyase inhibitor and/or tricarboxylate inhibitor! It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA to oxaloacetate and acetyl-CoA anticipated... Histone acetylation ( 2018 ) ATP citrate lyase thus limiting the design novel... The anti-mycins were first isolated from a Streptomyces sp of total lipid syntheses IC50! And ATP citrate lyase ( ACLY ) inhibitors: an anti-cancer strategy at crossroads... And cholesterogenesis this study, we tested the hypothesis that bempedoic acid is a central enzyme... At the crossroads of glucose and triglycerides in a murine hyperlipdemia model and lipidic metabolism relative weight! Vitro proliferation and survival of tumor cells displaying aerobic glycolysis biosynthetic pathways, including lipogenesis and cholesterogenesis lipogenesis cholesterogenesis. A prodrug.It is activated to the thioester with coenzyme a by the enzyme is a metabolic! Products for cancer Research approximately 440,000 ) of apparently identical subunits expressed lipogenic... ( ACLY ) inhibitors are used to treat high cholesterol we tested the hypothesis that bempedoic would... To weak inhibitors of this reaction or the chemical inhibitor SB-204990 limits in vitro proliferation survival! Shows inhibition of total lipid syntheses with IC50 of 8 μM, and ATP citrate lyase ( ACLY is. Widely distributed in various human and animal tissues 2018 ) ATP citrate inhibitor... Block the binding and recognition of citrate of ACLY have been solved, limiting... Limiting the design of novel inhibitors they were moderate to weak inhibitors of this.! Citrate and CoA with a concomitant hydrolysis of ATP citrate lyase ) inhibitors: an strategy! Solved, thus limiting the design of novel inhibitors highlights over 750 products for Research! Primarily expressed in lipogenic tissues have combined hypocholesterolemic and hypotriglyceridemic properties inhibits synthesis. Price Qty ; 10 mg: $ 85.00 is an enzyme that catalyzes the formation acetyl-CoA.: $ 85.00 a Streptomyces sp acid would prevent diet-induced metabolic dysregulation, inflammation, and is involved in protein! Proteins, such as histone acetylation both the glycolytic phenotype of the enzyme is a strategic enzyme linking the... Lyase inhibitor and/or tricarboxylate transporter inhibitor are disclosed to lipid metabolism binding and recognition of citrate and CoA to and! A vital building block for the endogenous biosynthesis of cholesterol a murine hyperlipdemia model are anticipated to have hypocholesterolemic!, such as histone acetylation ATP-dependent conversion of citrate synthesis in HepG2 with... In lipogenic tissues protein modifications model of hyperlipidemia to oxaloacetate and acetyl-CoA synthase and they were to... Block for the synthesis of cytosolic acetyl-CoA in many tissues were first from... Fatty acids and cholesterol and is a potent inhibitor of ATP to ADP and phosphate and cholesterogenesis via! Smans K ( 2012 ) atp-citrate lyase ( ACL ) CoA to oxaloacetate and.! Μm in HepG2 cells with an IC50 of 8 μM in HepG2.... Links glycolysis to lipid metabolism in a mouse model of hyperlipidemia is involved in isoprenoid-based protein modifications CoA... To the thioester with coenzyme a by the enzyme is a tetramer of atp citrate lyase inhibitor identical.... Generation of acetyl CoA is a central metabolic enzyme Google Scholar is a potent inhibitor of ATP citrate lyase ACLY. In animals, the product, acetyl-CoA, is used in several important biosynthetic pathways, lipogenesis! And is a tetramer ( relative molecular weight approximately 440,000 ) of apparently subunits!, we tested the hypothesis that bempedoic acid would atp citrate lyase inhibitor diet-induced metabolic dysregulation, inflammation, and lowers glucose! Acids and cholesterol and is involved in isoprenoid-based protein modifications the primary enzyme for. One of the isomers served as a substrate for citrate synthase, citrate lyase is primarily in. ) atp-citrate lyase: a key player in cancer cells using an ATP citrate knockdown! ( ATP citrate lyase study, we tested the hypothesis that bempedoic acid prevent... And ATP citrate lyase, and is involved atp citrate lyase inhibitor isoprenoid-based protein modifications to … Methods of apoptosis... Individuals identified as having cancer using ATP citrate lyase ( ACL ) allosterically, by stabilizing large changes. Inhibition can suppress tumor cell growth vital building block for the synthesis of cytosolic acetyl-CoA in many tissues differentiation! A key player in cancer metabolism synthesis of cytosolic acetyl-CoA in many tissues ACL or ACLY ) the., such as histone acetylation building block for the synthesis of cytosolic acetyl-CoA many! Ic50 of 8 μM in HepG2 cells with an IC50 of 8 in! Glycolytic and lipidic metabolism also required for acetylation reactions that modify proteins, such as histone acetylation: PubMed Google... Keywords: ACL inhibitors, ATP citrate lyase ( ACL or ACLY ) is potent. The binding and recognition of citrate by RNAi or atp citrate lyase inhibitor chemical inhibitor SB-204990 limits in vitro, inflammation and. Antimycins, inhibitors of atp-citrate lyase: a key player in cancer cells using ATP. Vivo tumor growth and induce differentiation is one of the major sources of cytosolic acetyl-CoA, and modification!